Gene · 347
Papers2,410
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 2,410
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multi-platform omics analysis reveals molecular signature for COVID-19 pathogenesis, prognosis and drug target discovery. | Signal Transduct Target Ther | 2021 | 33859163 | PubTator, text mining | PubMed |
| The use of proteomics for blood biomarker research in premature infants: a scoping review. | Clin Proteomics | 2021 | 33853516 | PubTator, text mining | PubMed |
| Study on the gene signature related to immune microenvironment on viral and nonviral infections of hepatocellular carcinoma. | Medicine (Baltimore) | 2021 | 33847635 | PubTator, text mining | PubMed |
| Association between apolipoprotein gene polymorphisms and hyperlipidemia: a meta-analysis. | BMC Genom Data | 2021 | 33836655 | PubTator, text mining | PubMed |
| Sex-differences in circulating biomarkers during acute myocardial infarction: An analysis from the SWEDEHEART registry. | PLoS One | 2021 | 33831096 | PubTator, text mining | PubMed |
| An R package for divergence analysis of omics data. | PLoS One | 2021 | 33819273 | PubTator, text mining | PubMed |
| Aqueous Humor Proteomic Alterations Associated with Visual Field Index Parameters in Glaucoma Patients: A Pilot Study. | J Clin Med | 2021 | 33808966 | PubTator, text mining | PubMed |
| Fetal High-Density Lipoproteins: Current Knowledge on Particle Metabolism, Composition and Function in Health and Disease. | Biomedicines | 2021 | 33808220 | PubTator, text mining | PubMed |
| Circulating Extracellular Vesicles As Biomarkers and Drug Delivery Vehicles in Cardiovascular Diseases. | Biomolecules | 2021 | 33808038 | PubTator, text mining | PubMed |
| The Amniotic Fluid Cell-Free Transcriptome Provides Novel Information about Fetal Development and Placental Cellular Dynamics. | Int J Mol Sci | 2021 | 33807645 | PubTator, text mining | PubMed |
| Nanoproteomic Approach for Isolation and Identification of Potential Biomarkers in Human Urine from Adults with Normal Weight, Overweight and Obesity. | Molecules | 2021 | 33806905 | PubTator, text mining | PubMed |
| Approaches to Improve Endometrial Receptivity in Case of Repeated Implantation Failures. | Front Cell Dev Biol | 2021 | 33796523 | PubTator, text mining | PubMed |
| Screening of osteoarthritis diagnostic markers based on immune-related genes and immune infiltration. | Sci Rep | 2021 | 33782454 | PubTator, text mining | PubMed |
| Proteomics of serum extracellular vesicles identifies a novel COPD biomarker, fibulin-3 from elastic fibres. | ERJ Open Res | 2021 | 33778046 | PubTator, text mining | PubMed |
| Diet affects glycosylation of serum proteins in women at risk for cardiometabolic disease. | Eur J Nutr | 2021 | 33770218 | PubTator, text mining | PubMed |
| Critical role of mass spectrometry proteomics in tear biomarker discovery for multifactorial ocular diseases (Review). | Int J Mol Med | 2021 | 33760148 | PubTator, text mining | PubMed |
| Phenotypic and biochemical characteristics and molecular basis in 36 Chinese patients with androgen receptor variants. | Orphanet J Rare Dis | 2021 | 33750429 | PubTator, text mining | PubMed |
| A novel immuno-oncology algorithm measuring tumor microenvironment to predict response to immunotherapies. | Heliyon | 2021 | 33748492 | PubTator, text mining | PubMed |
Network Pharmacology-Based Approach to Comparatively Predict the Active Ingredients and Molecular Targets of Compound Xueshuantong Capsule and Hexuemingmu Tablet in the Treatment of Proliferative Diabetic Retinopathy. | Evid Based Complement Alternat Med | 2021 | 33747106 | PubTator, text mining | PubMed |
| ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. | Hum Mol Genet | 2021 | 33729478 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/347/papers?page=44